Orion Biotech Opportunities ^{Priced, Nasdaq: ORIAU}

We are a newly incorporated blank check company. While we may pursue an acquisition opportunity in any business, industry, sector, or geographical location, we intend to focus on the biotechnology and life sciences industries. In particular, we will target North American, European, and Asian healthcare companies with the potential to drive transformational change through the development and commercialization of novel therapies or technologies, areas in which our team has extensive operating, investing and transactional experience. Our sponsor is affiliated with MSD Partners and Panacea. Panacea is a leading venture capital firm focused on early and growth stage healthcare companies globally. MSD Partners is an investment adviser registered with the SEC under the Investment Advisers Act of 1940, as amended, which was established in 2009, by partners of MSD Capital. Orion will benefit from Panacea’s relationship network and extensive biotechnology and life sciences investing, development, financial, and operational expertise. Orion will also benefit from MSD Partners’ depth of investment experience across asset classes through different economic cycles, its proprietary relationships, and its reputation in the marketplace as a preferred partner.